Delivery Order SPE2DX15D9312-SPE2DX24FDEBD
- Not listed
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against the Defense Logistics Agency Troop Support Medical pharmaceutical prime vendor contract to provide 4563107239 ENTYVIO 300 MG VIALS with a potential value of $57,747.24. The delivery order has a completion date of January 5, 2024 and was awarded on December 13, 2023. DMS Pharmaceutical Group will deliver the pharmaceutical products to facilities located in Park Ridge, Illinois. As a woman-owned small business...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $57,747.24 by the Defense Logistics Agency to provide 4562852686 units of Entyvio 300 mg vials. The delivery order was awarded on November 15, 2023 under DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to supply pharmaceuticals and medical supplies with a total potential value of up to $5 million through December 2025. As a woman-owned small business and...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $28,873.62 by the Defense Logistics Agency to provide 4563079612 ENTYVIO 300 MG VIALS. This delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to supply pharmaceutical items and medical products with a potential value of up to $5 million through December 2025. As a woman-owned small business and pharmaceutical wholesaler, DMS...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $48,122.70 by the Defense Logistics Agency to provide 4562986926 units of Entyvio 300 mg vials. The delivery order was awarded on November 30, 2023 under DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to supply pharmaceuticals and medical supplies with a potential value of up to $5 million through December 2025. As a woman-owned small business and pharmaceutical...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against the Defense Logistics Agency Troop Support Medical pharmaceutical prime vendor contract to provide 4563079611 ENTYVIO 300 MG VIALS. The $28,873.62 order has a completion date of January 3, 2024 and was awarded on December 11, 2023 without a set-aside designation. DMS Pharmaceutical Group will deliver the pharmaceutical products to facilities supported by the Defense Logistics Agency located in Park Ridge,...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against the Defense Logistics Agency Troop Support Medical pharmaceutical prime vendor contract to provide 4562612628 ENTYVIO 300 MG VIALS. The order has a potential value of $44,398.90 and requires completion by November 15, 2023. As the prime contractor, DMS Pharmaceutical Group will supply the specified pharmaceutical item to Defense Logistics Agency Troop Support Medical facilities from its location in Park...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 300 mg vials of the pharmaceutical product ENTYVIO. The order has a potential value of $29,572.08 and a completion date of January 25, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds multiple federal contracts and indefinite delivery vehicles with the Defense Logistics Agency to...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 300 mg vials of the pharmaceutical ENTYVIO. The contract has a potential value of $118,288.32 and a completion date of January 26, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that holds multiple federal contracts and indefinite delivery vehicles with the Defense Logistics Agency to...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at eighty-six thousand six hundred twenty dollars and sixty-eight cents ($86,620.68) by the Defense Logistics Agency (DLA) to supply ENTYVIO 300 MG VIALS. This delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with DLA to provide pharmaceutical supplies and medical products with a potential value of up to five million dollars through December 2025. As a woman-owned...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide ENTYVIO 300 MG VIALS. The total potential value of the award is $141,773.70 and the period of performance ends on June 24, 2022. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides a wide range of brand and generic prescription and over-the-counter drug supplies to the federal government,...
- SPE2DX15D9312Indefinite Delivery Contract
- SPE2DX15D9312-SPE2DX24FDEBDDelivery Order
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against the Defense Logistics Agency Troop Support Medical pharmaceutical prime vendor contract to provide 4562661629 ENTYVIO 300 MG VIALS with a potential value of $14,436.78. The delivery order has a completion date of November 17, 2023 and was awarded on October 26, 2023 without a set-aside designation. As a woman-owned small business and woman-owned business, DMS Pharmaceutical Group will supply the Entyvio medication to fulfill requirements at Defense Logistics Agency Troop Support Medical facilities. Additionally, DMS Pharmaceutical Group currently holds an indefinite delivery contract with the Defense Logistics Agency, valued at up to $5 million through December 2025, to provide various medical supplies including atropine, Surgilube lubricant, heparin, and Narcan nasal spray to support military treatment centers worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.4k | 10/26/23 |